Showing results (71-80 of 154) with videos related to
Sort By:
Pageof 16
Gut|September 1, 1994
Studies on the enteropathy associated with primary hypogammaglobulinaemiaK Teahon, A D Webster, A B Price, et al.Digestion|January 1, 1989
Intestinal permeability to 51Cr-labelled ethylenediaminetetraacetate in food-intolerant subjectsG Scadding, I Bjarnason, J Brostoff, et al.Scandinavian Journal of Gastroenterology. Supplement|January 1, 1989
Effect of prostaglandin on indomethacin-induced increased intestinal permeability in manI Bjarnason, P Smethurst, P Clark, et al.Gastroenterology|July 13, 2000
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel diseaseJ A Tibble, G Sigthorsson, S Bridger, et al.Gut|March 1, 1992
Intestinal permeability in patients with Crohn's disease and their first degree relativesK Teahon, P Smethurst, A J Levi, et al.Gut|March 1, 1991
Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in manI Bjarnason, B Fehilly, P Smethurst, et al.Gut|March 1, 1996
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteriaA Macpherson, U Y Khoo, I Forgacs, et al.The Biochemical Journal|March 15, 1980
Requirement for guanosine triphosphate for cholera-toxin-catalysed incorporation of adenosine diphosphate ribose into rat liver plasma membranes and for activation of adenylate cyclaseC A Doberska, A J MacPherson, B R MartinSeminars in Immunology|December 6, 2011
The function of secretory IgA in the context of the intestinal continuum of adaptive immune responses in host-microbial mutualismM B Geuking, K D McCoy, A J MacphersonArthritis and Rheumatism|August 1, 1994
Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugsJ Hayllar, T Smith, A Macpherson, et al.Pageof 16